A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Sangamo Therapeutics Inc.’s current trading price is -76.48% away from its 52-week high, while its distance from the 52-week low is 27.97%. The stock’s price range for this time frame has been between $1.18 and $6.42. The trading volume of the company’s shares in the Healthcare reached around 2.67 million for the day, which was evidently higher than the average daily volume of 2.35 million over the last three months.
The current stock price for Sangamo Therapeutics Inc. (SGMO) is $1.51. The stock experienced a significant increase during the last trading session, reaching $1.6187 after opening at $1.38. It dipped to a low of $1.38 before ultimately closing at $1.36.
Unlock the Hottest Top 10 Penny Stocks Today! Discover Now
Dive into the world of lucrative penny stocks with MarketClub's groundbreaking "Smart Scan" technology! Get an instant snapshot of the top 50 high volume stocks with a clear direction and outstanding liquidity - in other words, the strongest trending. To unlock this exclusive list, simply provide your first name, last name, and email for instant access.
Gain Access to Top 10 Penny Stocks Now!.
Sponsored
Sangamo Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. Over the past year, the company’s stock reached a high of $6.42 on 08/15/22, while the lowest price during the same period was $1.18 on 05/10/23.
How Financial Performance Impacts Market Capitalization
Sangamo Therapeutics Inc. (SGMO) has experienced a quarterly decline of -48.11% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 259.51M and boasts a workforce of 478 employees.
Decoding Analysts’ Ratings for Sangamo Therapeutics Inc.
As of right now, 7 analysts are rating Sangamo Therapeutics Inc. as a BUY, 1 of the polled analysts branded the stock as an OVERWEIGHT, 3 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.3642, with a change in price of -1.2700. Similarly, Sangamo Therapeutics Inc. recorded 1,925,088 in trading volume during the last 100 days, posting a change of -45.68%.
How SGMO’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for SGMO stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
SGMO Stock Stochastic Average
Sangamo Therapeutics Inc.’s raw stochastic average for the past 50 days is currently at 28.21%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 55.00%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 34.44% and 26.11%, respectively.
SGMO Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant loss of -51.91% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -58.63%. Over the past 30 days, the price of SGMO has leaped by -8.48%. And in the last five days, it has surged by 16.15%.
